Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

CO2 Capsol – Presentation at Sparebank 1 Markets Energy Conference on 1 March 2023

Oslo, Norway - 24 February 2023CO2 Capsol’s Chief Executive Officer Jan Kielland will be presenting at theSparebank 1 Markets’ Energy Conference on 1 March 2023 as part of the CCS panelat 11:20-12.45 CET.Link to the conference program:https://emaileditor.provisoevent.no/web-site/d0014d9e-23a5-466e-a05c-bd1a725b291a/pages/program 2 MarchFor further information, please contact:Ingar BerghChief Financial OfficerCO2 Capsol AS+47 926 20 330ingar.bergh@co2capsol.comAbout CO2 CapsolCO2 Capsol is a carbon capture technology provider with a goal to accelerate the

OXE Marine AB (publ) Interim report 1 October to 31 December 2022

OXE Marine AB (publ) Interim Report Fourth Quarter 2022 Results presented in the interim report are consolidated from 16 February 2022 to 31 December 2022 following the completion of the acquisition of Diesel Outboards and Outdoor Network Manufacturing on 16 February 2022. Consolidated results include legal entities; OXE Marine AB (Sweden), OXE Marine INC (US) and OXE Marine Manufacturing INC (US). Furthermore, consolidated results do not have comparative figures as it is the first year of preparing consolidated financials. Where illustrated in the text, graphs and tables, prior

The Stockmann Group’s Financial Statements Bulletin 2022

The Stockmann Group’s annual revenue and profit clearly improved with an all-time high revenue and operating result for LindexSTOCKMANN plc, Financial Statement Release, 24.2.2023 at 8.00 EET   October–December 2022: - The Stockmann Group’s revenue decreased by 1.8% and was EUR 272.6 million (277.5).- Gross margin stood at 57.4% (57.7).- The adjusted operating result was EUR 26.1 million (29.6).- Operating result was EUR 24.6 million (50.6).- Earnings per share were EUR 0.11 (0.23).- Net result for the quarter amounted to EUR 17.6 million (35.3).- Lindex’s operating

Notice to Stockmann’s Annual General Meeting

STOCKMANN plc, Notice to general meeting 24.2.2023 at 8:00 EET   Notice is given to the shareholders of Stockmann plc ("Stockmann" or the "Company") to the Annual General Meeting to be held on Wednesday 22 March 2023 at 14:00 (Finnish time) at Pikku-Finlandia at the address Karamzininranta 4, FI-00100 Helsinki, Finland. The reception of participants that have registered for the meeting and the distribution of voting tickets will commence at 12:30 (Finnish time) at the meeting venue.   Shareholders can also exercise their right to vote by voting in advance. Instructions for

TOMRA: 4Q 2022 - Record revenues in all divisions and order intake growth

TOMRA ended fourth quarter 2022 with all-time-high revenues and continued growth in comparable currencies. All three divisions had record quarterly revenues. The gross margins are improving, but still not back to a satisfactory level. Revenues in the fourth quarter 2022 amounted to 3,477 MNOK compared to 3,050 MNOK in fourth quarter last year. Currency adjusted revenues were up 7% for TOMRA Group. At division level, currency adjusted revenues were up 6% in Collection, up 4% in Recycling, and up 9% in Food. Gross margin was 42.4% in fourth quarter 2022, down from 43.6% in fourth

Notice of ABB’s Annual General Meeting on March 23, 2023

Zurich, Switzerland, February 24, 2023ABB today published the invitation to its Annual General Meeting (AGM), which will be held on Thursday, March 23, 2023. The invitation can be found attached and at www.abb.com/agm . ABB is a technology leader in electrification and automation, enabling a more sustainable and resource-efficient future. The company’s solutions connect engineering know-how and software to optimize how things are manufactured, moved, powered and operated. Building on more than 130 years of

ABB publishes its first Integrated Report

Zurich, Switzerland, February 24, 2023Ad hoc Announcement pursuant to Art. 53 Listing Rules of SIX Swiss Exchange · Report covers ABB’s 2022 financial and sustainability performance · New 2025 mid-term sustainability targets for emissions in own operations and suppliers’ · Reduction of company’s own GHG emissions by 65% since 2019 ABB today published its first integrated report, which highlights progress against the company’s strategy and demonstrates how ABB creates value holistically for its stakeholders in the short-, medium- and long-term. As ABB’s primary report at Group

Lundin Gold Declares Quarterly Dividend

VANCOUVER, BC, Feb. 23, 2023 /CNW/ - Lundin Gold Inc. (TSX: LUG; Nasdaq Stockholm: LUG; OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased to announce that its Board of Directors has declared a quarterly cash dividend of US$0.10 per common share.  The dividend will be payable on March 31, 2023, to shareholders of record at the close of business on March 13, 2023. This dividend qualifies as an ”eligible dividend” for Canadian income tax purposes. Based on today’s closing price of the Company’s common shares on the Toronto Stock Exchange ("TSX") of CAD$13.04, this dividend of US$0.

Lundin Gold Reports Fourth Quarter and Full Year Results

Production and Cost Performance Beats Guidance for Second Year RunningVANCOUVER, BC, February 23, 2023 /CNW/ - Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) ("Lundin Gold" or the "Company") is pleased to report results for the fourth quarter and year ended December 31, 2022 (the “2022 Year”). Lundin Gold’s year is highlighted by its production of 476,329 oz of gold at an all-in sustaining cost (“AISC”)[1] of $805 per oz, beating production guidance of 430,000 to 460,000 oz and AISC guidance of $820 to $870 per oz, respectively, and resulting in free cash flow¹ of $269

FDA approves once-weekly efanesoctocog alfa, a new class of high-sustained factor VIII therapy for haemophilia A

Sobi® today announced that the US Food and Drug Administration (FDA) has approved efanesoctocog alfa [Antihemophilic Factor (Recombinant), Fc-VWF-XTEN Fusion Protein-ehtl], a first-in-class, high-sustained factor VIII replacement therapy for adults and children with haemophilia A. Efanesoctocog alfa is the first and only haemophilia A treatment that provides patients with normal to near-normal factor VIII activity levels for a significant part of the week with once-weekly dosing, resulting in superior protection from bleeds compared to existing factor VIII prophylaxis.   Haemophilia A

Publication of the NAXS 2022 Annual Report

The NAXS 2022 Annual Report for is now available on the Company’s website, www.naxs.se. The Annual Report is also attached to this notice. Contact information: Gösta Lundgren, interim CEO Telephone: +46 707104788 This information is information that NAXS AB (publ) is obliged to make public pursuant to the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 21.30 CET on February 23, 2023. This press release and further information is available on the Company’s website: www.naxs.se NAXS AB (publ)

Nordea Bank Abp: Repurchase of own shares on 23.02.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares23.02.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 23.02.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number Weighted average Total cost, EUR* **venue (MIC of price / share, EUR* Code) shares **XHEL 121,618 11.83 1,438,716.62CEUX 128,232 11.83 1,517,203.24TQEX 17,655 11.83 208,824.34XSTO 118,230 11.83 1,399,075.15

The Nomination Committee's proposal for a new board member and proposal of board of directors of LEAX Group AB

The Nomination Committee of LEAX Group AB has announced that they have informed the company that it is proposing Lina Ankargren as a new member of the Board. The board members Roger Berggren, Lars Davidsson, Jonas Lundgren, Lars Wrebo and Jessica Alenius are proposed for re-election.Bent Wessel-Aas has announced that he will not run for re-election to the board. The Nomination Committee proposes that the 2023 Annual General Meeting elects six ordinary Board members without deputies consisting of the following persons: Roger Berggren (re-election), Chairman Lars Davidsson (re-

Statement of the Board of Directors of Nixu Corporation Regarding the Voluntary Recommended Public Cash Tender Offer by DNV AS

Nixu Corporation, Stock exchange release, 23 February 2023, 8.00 p.m. EETNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND OR SOUTH AFRICA OR IN ANY OTHER JURISDICTION IN WHICH THIS TENDER OFFER WOULD BE PROHIBITED BY APPLICABLE LAW. On 16 February 2023, DNV AS (the “Offeror”) announced that it will make a voluntary recommended public cash tender offer for all the issued and outstanding shares (the “Shares”) that are not held by Nixu Corporation (“Nixu” or the “Company”) or any of its

Proposal for Board of Directors of AB Volvo

Press information from AB Volvo’s Election Committee The Election Committee of AB Volvo proposes Bo Annvik to be elected as new Board member at the Annual General Meeting on April 4, 2023. The Election Committee also proposes the re-election of the Chairman of the Board Carl-Henric Svanberg, as well as Board members Matti Alahuhta, Jan Carlson, Eric Elzvik, Martha Finn Brooks, Kurt Jofs, Martin Lundstedt, Kathryn V. Marinello, Martina Merz and Helena Stjernholm. Hanne de Mora will not stand for re-election.Bo Annvik, 57, has many years of experience from leading positions in global

Overlord Arrives in Stellaris: Console Edition on March 8, 2023

New Vassalization Mechanics, Origins, and More arriving in Expansion Pass FiveSTOCKHOLM - Feb 23, 2023 - Paradox Interactive, a developer and publisher of games that add more vassals and less hassles, today announced that Overlord, a full expansion for Stellaris that focuses on deeper empire management, will arrive on Xbox and PlayStation consoles on March 8, 2023. From specialized vassals to powerful new megastructures, Overlord will offer fans multiple and exciting ways to control their galactic empires. Overlord is included as part of Stellaris Expansion Pass Five, available for purchase

INFORMATION ABOUT NAV AS OF 31 DECEMBER 2022 AND CORRECTION OF PREVIOUSLY STATED NAV AS OF 30 JUNE 2022

PRESS RELEASE23 February 2023, at 6:15 p.m. – Stockholm.Arte Collectum I AB (publ)www.artecollectum.comArte Collectum I AB, org. no. 559350–6909, (“Fund”), announces that the net asset value (“NAV”) in the Fund as of 31 December 2022 amounted to 9,700 euro (97 percent). When publishing the interim report per 30 June 2022, had the establishment costs not correctly been deducted from the Fund’s assets. As a result, the NAV in the Fund was incorrectly stated as EUR 10,000 (100 per cent) as of 30 June 2022. The correct NAV as of 30 June 2022, was instead EUR 9,705 (97.05 per cent).

Repurchase of own shares

Tietoevry Corporation          STOCK EXCHANGE RELEASE          23 February 2023  7.00 p.m. EET   Date:  23 February 2023 Exchange transaction: Buy                       Share class:  TIETO Amount, shares: 41 699 Average price/share, EUR 30.1178 Total price, EUR: 1 255 882.14   The number of shares held by Tietoevry Corporation after the completion of transactions: 251 865 shares.                         On behalf of Tietoevry Corporation        EVLI PLC                Joachim Dannberg                  For further information, please

ODI Pharma AB: Publication of half-year report 2022/2023

ODI Pharma AB (“ODI” or the “Company”) hereby publishes its half-year report for the period July – December 2022. The report is available as an attached document to this press release and on the Company’s website (www.odipharma.com). Below is a summary of the report.Second quarter (2022-10-01 – 2022-12-31) The Group's net sales amounted to SEK 73,276 (458,620). The Group's loss after financial items amounted to SEK -1,735,431 (-1,401,502). Result per share amounted to SEK -0.11 (-0.09).* Six months (2022-07-01 – 2022-12-31) The Group’s net sales amounted to SEK 101,282 (458,

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 23.02.2023

United Bankers Plc NOTIFICATION   23.02.2023 at 18:30   UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 23.02.2023   Date 23.02.2023  Exchange transaction Buy  Share class UNITED  Amount 380  Average price/share 14.9342 EURHighest price/share 15.0000 EURLowest price/share 14.9000 EURTotal price 5,675.00 EUR        The shares held by United Bankers Plc on 23.02.2023   UNITED 25,448         On behalf of United

Clinical Laserthermia Systems AB enters underwriting commitments in the ongoing exercise of warrants of series TO 5 B corresponding to approximately SEK 2.6 million

Lund, Sweden – Clinical Laserthermia Systems AB ("CLS" or the "Company") hereby announces that the Company has agreed on underwriting commitments (so-called “top-down” or “top guarantee”) in the ongoing exercise of warrants of series TO 5 B ("TO 5 B”). The underwriting commitments covers a total of approx. SEK 2.6 million, corresponding to 20 percent of the issue proceeds that the Company can receive through the exercise of TO 5 B. The underwriters have also undertaken to exercise their TO 5 B to subscribe for new B-shares in CLS, corresponding to a total of approximately SEK 100,000.In the

Financial report for the 4th quarter 2022

· A quarter with high utilization and improved commercial terms across all geographical regions and vessel segments compared to 4Q 2021. · The market continues to strengthen despite a challenging macroeconomic environment. · Revenues for 4Q 2022 increased by 26 percent to MNOK 1,637 vs MNOK 1,303 in 4Q 2021. · EBITDA adjusted increased by 56 percent to MNOK 454 vs MNOK 291 in 4Q 2021. · The quarter experienced positive impact to equity following the strengthening of NOK against USD. · The highest quarterly order intake in the Company’s history with contracts signed for

Clinical Laserthermia Systems AB publishes Year-end report January – December 2022

Summary of the year-end report (relates to the Group)   Twelve months (01/01/2022–12/31/2022) · Net sales totaled SEK 6,268,000 (SEK 2 245,000). · Profit/loss after financial items totaled SEK -71,265,000 (SEK -64,141,000). · Basic and diluted earnings per share totaled SEK -0.85 (SEK -1.12). · The equity ratio at December 31, 2022, was 18,6% (31,7%).   Fourth quarter (10/01/2022–12/31/2022) · Net sales totaled SEK 4,295,000 (SEK 1,344,000). · Profit/loss after financial items amounted to SEK -19,618,000 (SEK -19,584,000). · Basic and diluted earnings per

There are no items matching the current filter
There are no more items matching the current filter
Back to top